Grape King Bio Ltd (1707.TW)
TWD 151.0
(0.0%)
TWD 151.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.53 Billion TWD | -2.08% |
| 2022 | 8.48 Billion TWD | 7.97% |
| 2021 | 7.85 Billion TWD | 4.24% |
| 2020 | 7.53 Billion TWD | -0.39% |
| 2019 | 7.56 Billion TWD | 3.23% |
| 2018 | 7.32 Billion TWD | -6.81% |
| 2017 | 7.86 Billion TWD | -0.69% |
| 2016 | 7.91 Billion TWD | 24.02% |
| 2015 | 6.38 Billion TWD | 14.82% |
| 2014 | 5.56 Billion TWD | 11.34% |
| 2013 | 4.99 Billion TWD | 24.0% |
| 2012 | 4.02 Billion TWD | 23.68% |
| 2011 | 3.25 Billion TWD | 17.96% |
| 2010 | 2.76 Billion TWD | 17.78% |
| 2009 | 2.34 Billion TWD | 189.3% |
| 2008 | 810.35 Million TWD | 20.42% |
| 2007 | 672.96 Million TWD | 17.18% |
| 2006 | 574.3 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.1 Billion TWD | 23.77% |
| 2024 Q1 | 1.69 Billion TWD | -31.83% |
| 2023 Q2 | 2.19 Billion TWD | 23.03% |
| 2023 Q1 | 1.78 Billion TWD | -30.74% |
| 2023 Q4 | 2.49 Billion TWD | 23.98% |
| 2023 Q3 | 2.01 Billion TWD | -8.21% |
| 2023 FY | 8.3 Billion TWD | -2.08% |
| 2022 Q3 | 1.99 Billion TWD | -12.86% |
| 2022 FY | 8.48 Billion TWD | 7.97% |
| 2022 Q2 | 2.28 Billion TWD | 39.78% |
| 2022 Q1 | 1.63 Billion TWD | -31.09% |
| 2022 Q4 | 2.57 Billion TWD | 29.15% |
| 2021 Q3 | 1.93 Billion TWD | -1.77% |
| 2021 FY | 7.85 Billion TWD | 4.24% |
| 2021 Q1 | 1.58 Billion TWD | -30.12% |
| 2021 Q2 | 1.96 Billion TWD | 24.46% |
| 2021 Q4 | 2.37 Billion TWD | 22.68% |
| 2020 Q1 | 1.67 Billion TWD | -24.77% |
| 2020 Q3 | 1.77 Billion TWD | -2.36% |
| 2020 Q4 | 2.26 Billion TWD | 27.33% |
| 2020 Q2 | 1.82 Billion TWD | 8.67% |
| 2020 FY | 7.53 Billion TWD | -0.39% |
| 2019 FY | 7.56 Billion TWD | 3.23% |
| 2019 Q3 | 1.75 Billion TWD | -9.58% |
| 2019 Q2 | 1.94 Billion TWD | 18.65% |
| 2019 Q1 | 1.63 Billion TWD | -22.92% |
| 2019 Q4 | 2.22 Billion TWD | 26.73% |
| 2018 Q1 | 1.54 Billion TWD | -33.0% |
| 2018 Q4 | 2.12 Billion TWD | 20.76% |
| 2018 Q3 | 1.75 Billion TWD | -7.58% |
| 2018 FY | 7.32 Billion TWD | -6.81% |
| 2018 Q2 | 1.9 Billion TWD | 23.62% |
| 2017 Q3 | 1.84 Billion TWD | -6.8% |
| 2017 Q1 | 1.73 Billion TWD | -18.02% |
| 2017 Q2 | 1.98 Billion TWD | 13.86% |
| 2017 Q4 | 2.29 Billion TWD | 24.54% |
| 2017 FY | 7.86 Billion TWD | -0.69% |
| 2016 Q1 | 1.77 Billion TWD | -0.32% |
| 2016 FY | 7.91 Billion TWD | 24.02% |
| 2016 Q4 | 2.12 Billion TWD | 9.61% |
| 2016 Q3 | 1.93 Billion TWD | -7.31% |
| 2016 Q2 | 2.08 Billion TWD | 17.74% |
| 2015 Q2 | 1.63 Billion TWD | 12.06% |
| 2015 Q1 | 1.45 Billion TWD | -7.28% |
| 2015 FY | 6.38 Billion TWD | 14.82% |
| 2015 Q4 | 1.77 Billion TWD | 17.6% |
| 2015 Q3 | 1.51 Billion TWD | -7.42% |
| 2014 Q3 | 1.33 Billion TWD | -6.67% |
| 2014 Q2 | 1.42 Billion TWD | 15.8% |
| 2014 Q1 | 1.23 Billion TWD | -8.2% |
| 2014 FY | 5.56 Billion TWD | 11.34% |
| 2014 Q4 | 1.57 Billion TWD | 17.95% |
| 2013 Q4 | 1.34 Billion TWD | 8.45% |
| 2013 Q2 | 1.33 Billion TWD | 24.56% |
| 2013 FY | 4.99 Billion TWD | 24.0% |
| 2013 Q1 | 1.07 Billion TWD | -6.46% |
| 2013 Q3 | 1.23 Billion TWD | -7.37% |
| 2012 Q3 | 1.01 Billion TWD | 0.14% |
| 2012 Q2 | 1.01 Billion TWD | 17.64% |
| 2012 Q1 | 858.97 Million TWD | -2.36% |
| 2012 FY | 4.02 Billion TWD | 23.68% |
| 2012 Q4 | 1.14 Billion TWD | 13.47% |
| 2011 Q2 | 841.17 Million TWD | 12.98% |
| 2011 Q1 | 744.5 Million TWD | -9.61% |
| 2011 Q4 | 879.75 Million TWD | 11.13% |
| 2011 FY | 3.25 Billion TWD | 17.96% |
| 2011 Q3 | 791.63 Million TWD | -5.89% |
| 2010 Q4 | 823.61 Million TWD | 15.84% |
| 2010 FY | 2.76 Billion TWD | 17.78% |
| 2010 Q3 | 710.98 Million TWD | 0.7% |
| 2010 Q2 | 706.03 Million TWD | 35.62% |
| 2010 Q1 | 520.59 Million TWD | 0.0% |
| 2009 FY | 2.34 Billion TWD | 189.3% |
| 2008 FY | 810.35 Million TWD | 20.42% |
| 2007 FY | 672.96 Million TWD | 17.18% |
| 2006 FY | 574.3 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Standard Chem & Pharm CO., LTD. | 2.72 Billion TWD | -213.114% |
| Maywufa Company Ltd. | 854.37 Million TWD | -898.808% |
| ScinoPharm Taiwan, Ltd. | 1.21 Billion TWD | -601.778% |
| Lotus Pharmaceutical Co., Ltd. | 8.33 Billion TWD | -2.332% |
| LIWANLI Innovation Co., Ltd. | 15.08 Million TWD | -56477.193% |
| YungShin Global Holding Corporation | 2.91 Billion TWD | -193.142% |
| PhytoHealth Corporation | 67.64 Million TWD | -12515.552% |
| SCI Pharmtech, Inc. | 350.32 Million TWD | -2335.906% |
| Formosa Laboratories, Inc. | 1.9 Billion TWD | -348.361% |
| PharmaEssentia Corporation | 4.49 Billion TWD | -89.842% |
| Bora Pharmaceuticals Co., LTD. | 6.99 Billion TWD | -22.06% |